Skip to content

Advertisement

Standards in Genomic Sciences

Open Access

Genomic insights into Mycobacterium simiae human colonization

  • José L. Steffani-Vallejo1,
  • Marion E. Brunck3,
  • Erika Y. Acosta-Cruz1, 2, 4,
  • Rafael Montiel2 and
  • Francisco Barona-Gómez1Email author
Standards in Genomic Sciences201813:1

https://doi.org/10.1186/s40793-017-0291-x

Received: 30 June 2017

Accepted: 24 November 2017

Published: 8 January 2018

Abstract

Mycobacterium simiae (Karassova V, Weissfeiler J, Kraszanay E, Acta Microbiol Acad Sci Hung 12:275-82, 1965) is a slow-growing nontuberculous Mycobacterium species found in environmental niches, and recently evidenced as an opportunistic Human pathogen. We report here the genome of a clinical isolate of M. simiae (MsiGto) obtained from a patient in Guanajuato, Mexico. With a size of 6,684,413 bp, the genomic sequence of strain MsiGto is the largest of the three M. simiae genomes reported to date. Gene prediction revealed 6409 CDSs in total, including 6354 protein-coding genes and 52 RNA genes. Comparative genomic analysis identified shared features between strain MsiGto and the other two reported M. simiae genomes, as well as unique genes. Our data reveals that M. simiae MsiGto harbors virulence-related genes, such as arcD, ESAT-6, and those belonging to the antigen 85 complex and mce clusters, which may explain its successful transition to the human host. We expect the genome information of strain MsiGto will provide a better understanding of infective mechanisms and virulence of this emergent pathogen.

Keywords

Mycobacterium simiae Nontuberculous mycobacteriaOpportunistic pathogen

Introduction

Contrasting with the declining incidence of Mycobacterium tuberculosis -caused tuberculosis, the increasing number of nontuberculous mycobacteria infections is concerning. Amongst NTM, the Mycobacterium simiae complex contains 19 species [1], including M. simiae [2], which is considered the most important species in terms of its clinical relevance [3]. M. simiae is a slow-growing saprophyte that has been isolated from several environments including water and soil [3, 4]. In addition to thriving in environmental niches, M. simiae has been associated to infections in both immunocompromised [4, 5] and immunocompetent patients [6], with clinical cases reported worldwide [5, 6]. Thus, M. simiae is considered an emergent pathogen [79]. Previous sequencing efforts have provided draft genome sequences for M. simiae , namely, strains MO323 (accession PRJNA276839) and DSM 44165 (accession PRJEB1560) [10], which were isolated in early years from the United States of America (1989) and India (1965), respectively. We expand here on this genomic data by reporting the genome sequence of a clinical isolate from a Mexican patient (bronchial lavage) obtained in 2011, designated as MsiGto, which is approximately 745 Kbp and 901 Kbp larger than the previously published M. simiae genomes, respectively. Additionally, we perform a comparative analysis between the genomes of strain MsiGto and the previously reported DSM 44165 and MO323 strains to provide insights that could unearth the transition from environmental bacteria to pathogenic NTM organisms.

Organism information

Classification and features

To identify strain MsiGto as an M. simiae isolate, typical DNA markers for mycobacterial identification, such as the 16S rRNA, rpoB and hsp65 genes [1113] were localized on the sequenced MsiGto genome, and compared to other publicly available sequences using BLASTN on its default settings. The MsiGto 16S rRNA gene exhibited 100% identity with previously deposited M. simiae sequences (strains DS39, DS34, DS31, DS24, DS19, DS3, DS2, MO323 and ATCC 25275). The MsiGto rpoB gene sequence showed 99% identity with M. simiae MO323. Similarly, there was 100% identity between the MsiGto and MO323 hsp65 genes. For comparison, a BLAST of these markers from DSM 44165 and MO323 evidenced a similar trend with 99% identity for the 16S rRNA gene and 100% identity for rpoB and hsp65. Figure 1 shows the phylogenetic position of M. simiae MsiGto within the M. simiae complex, based on a concatenated gene tree including the sequences of the 16S rRNA, rpoB and hsp65 genes (1507 bp in total).
Fig. 1

Phylogenetic tree showing the relationship of M. simiae MsiGto with selected species members of the M. simiae Complex, including 2 relevant M. simiae strains. Phylogenetic reconstruction was obtained using Bayesian inference. Numbers at the nodes are the values of posterior probabilities. The tree was obtained after 1 million generations with mixed model. Sequence data from Mycobacterium tuberculosis H37Rv was used as an outgroup

Further analysis such as the Average Nucleotide Identity and Average Amino Acid Identity, preformed as previously reported [14], confirmed the high resemblance between M. simiae MsiGto and M simiae strains MO323 and DSN 44165 (Table 1). The ANI values were above 95% in all cases, indicating that the compared organisms belong to the same species. Similar results were found using Genome-to-Genome Distance Calculator [15, 16] with a calculated distance of 0.0292 and a DNA-DNA hybridization estimate of 77.40% using the formula for draft genomes. These results provide a taxonomic background in which the genome insights presented in the following sections can better accounted for, namely, large genotype differences of MsiGto, despite close taxonomic relationships with DSM 44165 and MO323 strains.
Table 1

Average Nucleotide Identity (A) and Average Amino acid Identity (B) between M. simiae MsiGto and other M simiae strains sequenced to date

Organism

M. simiae MsiGto A/B

M. simiae DSM 44165

M. simiae MO323

M. simiae MsiGto

97.25/ 97.51

98.99/98.95

M. simiae DSM 44165

97.25/ 97.51

97.26/97.59

M. simiae MO323

98.99/98.95

97.26/97.59

Genome sequencing information

Genome project history

Despite M. simiae being one of the most relevant NTM due to its emergence as a human pathogen, the genomic features and genetic potential of this species remain poorly described. In collaboration with the State Laboratory of Public Health of Guanajuat, located in central Mexico, we had access to a clinical isolate of M. simiae , termed MsiGto. The sample was isolated from a 90 years old female patient from León, the largest and most industrialized city of the State of Guanajuato, México, in 2011 (Table 2). This sample was selected for genomic sequencing due to the emerging clinical importance of strains from the M. simiae complex worldwide [8, 9, 1719], combined with a lack of representative genomic sequences from Mexico to this date. The available genome sequences could allow comparative analyses in order to increase our understanding of this opportunistic bacterium.
Table 2

Classification and general features of Mycobacterium simiae MsiGto [51]

MIGS ID

Property

Term

Evidence codea

 

Classification

Domain Bacteria

TAS [52]

  

Phylum Actinobacteria

TAS [53]

  

Class Actinobacteria

TAS [54]

  

Order Actinomycetales

TAS [55, 56]

  

Family Mycobacteriaceae

[54, 56, 57]

  

Genus Mycobacterium

TAS [58, 59]

  

Species Mycobacterium simiae

IDA

 

Gram stain

Weakly Postive

IDA

 

Cell shape

Irregular rods

IDA

 

Motility

Non Motile

IDA

 

Sporulation

Nonsporulating

NAS

 

Temperature range

Mesophile

NAS

 

Optimum temperature

37 °C

NAS

 

pH range; Optimum

5.5–8; 7

IDA

 

Carbon source

Starch

IDA

MIGS-6

Habitat

Human Associated

NAS

MIGS-6.3

Salinity

Normal

NAS

MIGS-22

Oxygen requirement

Aerobic

NAS

MIGS-15

Biotic relationship

Parasitic

IDA

MIGS-14

Pathogenicity

Pathogenic

NAS

MIGS-4

Geographic location

Mexico/Guanajuato

NAS

MIGS-5

Sample collection

2014

NAS

MIGS-4.1

Latitude

Not Reported

NAS

MIGS-4.2

Longitude

Not Reported

NAS

MIGS-4.4

Altitude

Not Reported

NAS

aEvidence codes - IDA Inferred from Direct Assay, TAS Traceable Author Statement (i.e., a direct report exists in the literature), NAS Non-traceable Author Statement (i.e., not directly observed for the living, isolated sample, but based on a generally accepted property for the species, or anecdotal evidence). These evidence codes are from the Gene Ontology project [60]

Growth conditions and genomic DNA preparation

MsiGto was isolated from a sputum specimen. Briefly, 2 mL sample were transferred to a sterile tube and decontaminated by adding an equal volume of 4% NaOH with phenol red. The mix was immediately vortexed and incubated at 37 °C for 15 min. The liquefied sample was centrifuged at 3000 g at 4 °C for 15 min, the supernatant was discarded and pH was adjusted between the 6.5 and 7.2 range using 1 N HCL. Finally, 0.2 mL of sample were inoculated into Lowenstein-Jenssen slants (Difco) and incubated at 37 °C for three weeks.

Biomass was collected and suspended in phosphate buffered saline solution, pH 7.4, and inactivated by heating at 80 °C for 45 min. After centrifugation, genomic DNA was extracted from the pellet using the FastDNA SPIN Kit for Soil (MP Biomedicals) according to manufacturer’s instructions. Extracted gDNA was assessed for quantity and quality using a NanoDrop Spectrophotometer (Thermo Fisher Scientific).

Genome sequencing and assembly

The MsiGto genome was sequenced on a HiSeq 2000 platform with a 100 bp paired-end cycle according to standard Illumina protocols, at Macrogen facilities. Quality of the generated sequencing reads (13,676,836 reads, total read length: 1,381,360,436 bp) was checked with FastQC. Reads were filtered before assembly, such that both sequences in paired-end reads exhibited more than 90% bases of quality greater than or equal to Q20. Post-filtering Q20% was 97.69 and Q30% was 88.6 at the base level. The filtered reads were assembled using SOAP de novo aligner [20], yielding 50 contigs. Scaffolding was performed with SSPACE Standard [21] and resulted in 12 scaffolds, generating a genome size of 6.7 Mb with a coverage of 216X (Table 3).
Table 3

Project information

MIGS ID

Property

Term

MIGS 31

Finishing quality

Draft

MIGS-28

Libraries used

Paired End Illumina

MIGS 29

Sequencing platforms

Illumina HiSeq 2000

MIGS 31.2

Fold coverage

216

MIGS 30

Assemblers

SOAPdenovo

MIGS 32

Gene calling method

RAST

 

Locus Tag

B5M45

 

Genbank ID

MZZM00000000

 

GenBank Date of Release

April 17, 2017

 

GOLD ID

Ga0183212

 

BIOPROJECT

PRJNA378996

MIGS 13

Source Material Identifier

Mycobacterium simiae MsiGto

 

Project relevance

Medical, Evolutionary

Genome annotation

Gene prediction and functional annotation were performed using the Rapid Annotation using Subsystem Technology platform [22]. A prophage region prediction was completed using PHAST [23]. CRISPRs were searched using the CRISPR finder, and antibiotic resistance genes were investigated using Resistance Gene Identifier from the Comprehensive Antibiotic Resistance Database [24]. Genome-to-genome comparisons were performed using multiple approaches, including conservation analysis of protein families across genomes with the Protein Family Sorter from the PATRIC Platform [25], and comparing functionally related clusters using the function-based comparison of the RAST server. MsiGto and related genomes were also aligned using a genome-wide BLAST comparison, and visualized through the Artemis Comparative Tool [26] for manual inspection.

Genome properties

Genomic assembly yielded a total length of 6,684,413 bp fragmented in 50 contigs, the largest M. simiae genome reported to date. The MsiGto genome consists of a unique chromosome, as no plasmid DNA was found. The GC content of the genome was 66.08%, consistent with other reported M. simiae strains. Gene prediction analysis documented 3 rRNAs, 49 tRNAs and 6409 coding sequences. Out of these, 4462 genes (69.62%) were assigned to putative functions, and 3669 genes (approximately 62.57%) were assigned to clusters of orthologous groups functional categories. Sequence searches using RGI evidenced resistance genes to amynoglycosides, ethambutol and beta lactams, which is a concern as to date standard antibiotic regimes for this species include the use of ethambutol, the aminoglycoside amikacin, as well as the macrolides azithromycin and clarithromycin [27]. The genome properties and statistics are summarized in Tables 4 and 5. Gene distribution among the COG functional categories is shown in Table 6. A circular map of MsiGto chromosome is provided in Fig. 2.
Table 4

Summary of genome: one chromosome, no plasmids

Label

Size (Mb)

Topology

INSDC identifier

RefSeq ID

Chromosome

6,684,413

Circular

GenBank

NZ_MZZM00000000.1

Table 5

Genome statistics

Attribute

Value

% of Total

Genome size (bp)

6,684,413

100

DNA coding (bp)

5,978,008

89.43

DNA G + C (bp)

4,416,391

66.07

DNA scaffolds

15

100

Total genes

6369

100

Protein coding genes

6299

99.90

RNA genes

70

1.10

Pseudo genes

160

2.51

Genes in internal clusters

579

9.09

Genes with function prediction

4713

74.00

Genes assigned to COGs

5272

82.29

Genes with Pfams domains

5009

78.19

Genes with signal peptides

260

4.08

Genes with transmembrane helices

1292

20.29

CRISPR repeats

15

 
Table 6

Number of genes associated with general COG functional categories

Code

Value

%agea

Description

J

161

2.53

Translation, ribosomal structure and biogenesis

A

21

0.33

RNA processing and modification

K

448

7.05

Transcription

L

192

3.02

Replication, recombination and repair

B

1

0.01

Chromatin structure and dynamics

D

55

0.86

Cell cycle control, Cell division, chromosome partitioning

V

47

0.73

Defense mechanisms

T

218

3.43

Signal transduction mechanisms

M

159

2.50

Cell wall/membrane biogenesis

N

57

0.89

Cell motility

U

36

0.56

Intracellular trafficking and secretion

O

153

2.41

Posttranslational modification, protein turnover, chaperones

C

447

7.03

Energy production and conversion

G

243

3.82

Carbohydrate transport and metabolism

E

298

4.69

Amino acid transport and metabolism

F

82

1.29

Nucleotide transport and metabolism

H

210

3.30

Coenzyme transport and metabolism

I

558

8.78

Lipid transport and metabolism

P

239

3.76

Inorganic ion transport and metabolism

Q

494

7.77

Secondary metabolites biosynthesis, transport and catabolism

R

795

12.51

General function prediction only

S

358

5.63

Function unknown

1082

17.03

Not in COGs

aThe total is based on the total number of protein coding genes in the genome

Fig. 2

A graphical circular map of the M. simiae MsiGto genome keyed to the COGS functional categories. The circular map was generated using BASys web server [61]

Insights from the genome sequence

Extended insights

We report here the third genome sequence of M. simiae . MsiGto was isolated from a clinical sample obtained from an elderly woman, and is the largest M. simiae genome reported to date with an approximate 745 Kbp additional to the next largest genome (strain MO323). As pathogenic mycobacteria tend to undergo genome decay [28, 29], the large genomic size of MsiGto speaks out of an organism capable of thriving in both environmental conditions and in the human host. Indeed, by comparison, the genome of M. tuberculosis , an obligate pathogen, is significantly smaller with 4.41 Mb [30]. Meanwhile, with 6406 genes, the genome size of MsiGto is similar to that of the opportunistic pathogen Pseudomona aeruginosa (5570 predicted ORFs), which thrives in a variety of environments including soil, water, as well as the multiple human tissues it infects [31]. Analysis of the P. aeruginosa genome evidenced its large size arose from genetic expansion to enhance functional diversity rather than from gene duplication [32]. Interestingly, investigating protein families in MsiGto, in comparison with MO323 and DSM 44165, evidenced a larger proportion of proteins uniquely found in MsiGto (1.17 times more than DSM 44165 and 4.7 times more than MO323), suggestive of a relatively increased versatility in accordance with the multiple niches it can thrive in (Fig. 3).
Fig. 3

Venn diagram analysis showing the number of unique and shared family proteins as evidenced using PATRIC, between the M. simiae strains MO323, DSM 44165 and MsiGto

The genome of MsiGto is rich in virulence factors, genes conferring infective mechanisms, and host immune response evasion systems. Some of these proteins are common to other pathogenic mycobacteria, and shared by the two previously sequenced M. simiae genomes, such as ESAT-6, known to modulate host immune responses by affecting human T-cell responses [33, 34]. Interestingly, all M. simiae strains including MsiGto have three of the four antigen 85 complex genes (fbpA, fbpC, and fbpD) responsible for cell wall synthesis. The enzyme products of these genes are responsible for the conversion of trehalose monomycolate (TMM) into the Cord Factor trehalose dimycolate (TDM) [35], which is considered one of the most important virulence factors of mycobacteria [36]. Other genera belonging to the Mycobacteriaceae family that include both pathogenic and environmental species, such as Rhodococcus [37], Corynebacterium and Nocardia [38], also produce TDM [39].

Mammalian Cell Entry proteins are cell surface exposed proteins that play a crucial role in M. tuberculosis virulence by permitting the bacteria to enter mammalian cells and survive inside the macrophage, modulating the immune response [40, 41]. Mce clusters consist of 4 homologous operons in M. tuberculosis (mce1, mce2, mce3, mce4) with a similar arrangement: two genes encoding integral membrane proteins followed by six mce genes (A, B, C D, E and F) [40]. Mce proteins are also involved in lipid metabolism, acting as transporters and allowing cholesterol degradation to free carbon and energy for use by M. tuberculosis [41]. In the genome of MsiGto we found that the cluster mce3 is overrepresented. While the DSM 44165 and MO323 genomes present none and a single copy of mce3, respectively, two complete copies of the mce3 cluster were found in MsiGto. As the transition from an environmental organism to a pathogen has been associated with the acquisition of Mce genes in actinobacteria [42], and Mce3 proteins are expressed by M. tuberculosis during the infection phase [43], it is tempting to speculate the increased number of Mce3 copies found in MsiGto provided the strain with human infection potential.

The presence of multiple copies of these potential lipid transporters in mycobacterial genomes is consistent with the finding that pathogenic mycobacteria switch from carbohydrates to lipids as their main carbon and energy source inside cells [44]. The evolution of this locus, through duplication and divergence, has almost certainly contributed to virulence in mycobacteria, and even in other distantly related actinobacteria, such as Streptomyces [42, 45]. Given that the ability to acquire cholesterol from the host is crucial to maintain a chronic infection, we postulate that cells having a large mce copy number, such as that found in MsiGto, may potentially evolve pathogenicity relatively faster when compared with other environmental mycobacteria.

A total of 493 protein families were found exclusively present in MsiGto when compared to the other two available M. simiae genomes (MO323 and DSM 44165). Consistent with findings in the Pseudomonas aeruginosa [46] genome [32], it seems that MsiGto has undergone genome expansion. Within the gene pool unique to MsiGto we found the arginine/ornithine antiporter gene arcD, which is involved in the persistence of the zoonotic pathogen Streptococcus suis [47] in host cells [48]. Additional unique genes found in the MsiGto genome participate in aromatic amino acid metabolic pathways. For instance, 2-oxo-hepta-3-ene-1,7-dioic acid hydratase (hpcG gene, EC 4.2.1.80) participates in the degradation of tyrosine and the 2-keto-3-deoxy-D-arabino-heptulosonate-7-phosphate synthase I alpha participates in the synthesis of chorismate (aroG gene, EC 2.5.1.54). The latter is an interesting observation as tyrosine is a key nutrient source during infectious growth within macrophages of some pathogenic fungus [49, 50]. At this stage, however, it would be risky to rule out the involvement of these specific genes in important environmental functions that allow MsiGto to survive outside the host, or during both lifestyles.

Conclusions

Mycobacterium simiae is an organism of interest for genomic studies due to the scarce genomic data available, and its recent emergence as a human pathogen. Here we present the largest genome sequence of this species to date. The genome of M. simiae MsiGto presents characteristics in accordance with its adaptation to infect the Human host, with the presence of numerous virulence genes, plus some specific features that deserve further investigation. Additional M. simiae genomes, from both environmental and clinical isolates, should be sequenced to provide a wider evolutionary picture with functional implications. Indeed, our comparative analysis helps to better understand the evolution of host-pathogen interactions, and the molecular mechanisms of virulence, of this emergent human pathogen.

Abbreviations

ACT: 

Artemis Comparative Tool

CARD: 

Comprehensive Antibiotic Resistance Database

LaESaP: 

State Laboratory of Public Health of Guanajuato

MCE: 

Mammalian Cell Entry

NTM: 

Nontuberculous mycobacteria

RAST: 

Rapid Annotation using Subsystem Technology

RGI: 

Resistance Gene Identifier

TDM: 

Trehalose 6-dimicolate

TMM: 

Trehalose monomycolate

Declarations

Acknowledgements

We thank the Secretaría de Salud del Estado de Guanajuato and María Guadalupe Hurtado Torres from the LaESaP for their invaluable contribution to obtain the biological material, and Karina Gutiérrez-García for help with bioinformatic analysis.

Funding

The authors thank Fomix-Gto (grant number GTO-2011-C04–165962) for funding of this work, and Conacyt for a postdoctoral scholarship to EA (CVU No. 248685).

Authors’ contributions

JLS performed all bioinformatics analyses and contributed to the writing of the manuscript. MB participated in data analysis and writing of the manuscript. EA participated in sample processing for genomic sequencing and collaborate writing the first draft of the manuscript. RM and FBG conceived the study, supervised this project, and were responsible for completing the manuscript. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Evolution of Metabolic Diversity Laboratory, Unidad de Genómica Avanzada (Langebio), Cinvestav-IPN, Irapuato, Mexico
(2)
Paleogenomics Laboratory, Unidad de Genómica Avanzada (Langebio), Cinvestav-IPN, Irapuato, Mexico
(3)
Centro de Biotecnología FEMSA, Escuela de Ingeniería y Ciencias, Tecnológico de Monterrey, Monterrey, Mexico
(4)
Present address: Laboratorio de Biología Molecular, Facultad de Ciencias Químicas, Universidad Autónoma de Coahuila, Saltillo, Mexico

References

  1. Tortoli E. Microbiological features and clinical relevance of new species of the genus mycobacterium. Clin Microbiol Rev. 2014;27:727–52.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Karassova V, Weissfeiler J, Kraszanay E. Occurrence of atypical mycobacteria in Macacus rhesus. Acta Microbiol Acad Sci Hung. 1965;12(3):275–82.PubMedGoogle Scholar
  3. Makovcova J, Slany M, Babak V, Slana I, Kralik P. The water environment as a source of potentially pathogenic mycobacteria. J Water Health. 2014;12:254–63.View ArticlePubMedGoogle Scholar
  4. García Martos P, García Agudo L, Gonzáles Moya E, Galán F, Rodríguez Iglesias M. Article in press. Enferm Infecc Microbiol Clin. 2014:1–9.Google Scholar
  5. Van Ingen J, Boeree MJ, Dekhuijzen PNR, Van Soolingen D. Clinical relevance of mycobacterium simiae in pulmonary samples. Eur Respir J. 2008;31:106–9.View ArticlePubMedGoogle Scholar
  6. Cortés-Torres N, González-y-Merchand JA, González-Bonilla C, García-Elorriaga G. Molecular analysis of mycobacteria isolated in Mexican patients with different immunodeficiencies in a tertiary care hospital. Arch Med Res. 2013;44:562–9.View ArticlePubMedGoogle Scholar
  7. Hashemi-Shahraki A, Darban-Sarokhalil D, Heidarieh P, Mehdi Feizabadi M, Deshmir-Salameh S, Khazaee S, et al. Mycobacterium simiae: a possible emerging pathogen in Iran. Jpn J Infect Dis. 2013;66:475–9.View ArticlePubMedGoogle Scholar
  8. Qvist T, Katzenstein TL, Lillebaek T, Iversen M, Mared L, Andersen AB. First report of lung transplantation in a patient with active pulmonary Mycobacterium simiae infection. Transplant. Proc. Elsevier Inc. 2013:45, 803–845.Google Scholar
  9. Martínez-barricarte R, Megged O, Stepensky P, Casimir P, Averbuch D, Assous MV, et al. Mycobacterium simiae infection in two unrelated patients with different forms of inherited IFN-γR2 deficiency. 2015;34:904–9.Google Scholar
  10. Sassi M, Robert C, Raoult D, Drancourt M. Non-contiguous genome sequence of mycobacterium simiae strain DSM 44165(T). Stand Genomic Sci. 2013;8:306–17.View ArticlePubMedPubMed CentralGoogle Scholar
  11. Kim H, Kim SH, Shim TS, Kim MN, Bai GH, Park YG, et al. Differentiation of Myocobacterium species by analysis of the heat-shock protein 65 gene (hsp65). Int J Syst Evol Microbiol. 2005;55:1649–56.View ArticlePubMedGoogle Scholar
  12. Adékambi T, Colson P, Drancourt M. rpoB-based identification of nonpigmented and late-pigmenting rapidly growing mycobacteria. J Clin Microbiol. 2003;41:5699–708.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Pauls RJ, Turenne CY, Wolfe JN, Kabani AA. High proportion of novel mycobacteria species identified by 16S rDNA analysis among slowly growing AccuProbe-negative strains in a clinical setting. Am J Clin Pathol. 2003;120:560–6.View ArticlePubMedGoogle Scholar
  14. Rodriguez RL-M, Konstantinidis KT. The enveomics collection: a toolbox for specialized analyses of microbial genomes and metagenomes. Peer J Prepr. 2016; https://doi.org/10.7287/peerj.preprints.1900v1.
  15. Auch AF, von Jan M, Klenk H-P, Göker M. Digital DNA-DNA hybridization for microbial species delineation by means of genome-to-genome sequence comparison. Stand Genomic Sci. 2010;2:117–34.View ArticlePubMedPubMed CentralGoogle Scholar
  16. Auch AF, Klenk H-P, Göker M. Standard operating procedure for calculating genome-to-genome distances based on high-scoring segment pairs. Stand Genomic Sci. 2010;2:142–8.View ArticlePubMedPubMed CentralGoogle Scholar
  17. Campos CED, Dias CF, Unis G, de Souza Caldas PC, Redner P, de Carvalho LD, et al. First detection of Mycobacterium Triplex in Latin America. Int J Mycobacteriology. 2016;5:89–91.View ArticleGoogle Scholar
  18. Floyd MM, Guthertz LS, Silcox VA, Duffey PS, Jang Y, Desmond EP, et al. Characterization of an SAV organism and proposal of Mycobacterium Triplex sp. nov. J Clin Microbiol. 1996;34:2963–7.PubMedPubMed CentralGoogle Scholar
  19. List E. Validation of publication of new names and new combinations previously effectively published outside the IJSB. Int J Syst Bacteriol. 1997;54:601–2.Google Scholar
  20. Luo R, Liu B, Xie Y, Li Z, Huang W, Yuan J, et al. SOAPdenovo2: an empirically improved memory-efficient short-read de novo assembler. Gigascience. 2012;1:18.View ArticlePubMedPubMed CentralGoogle Scholar
  21. Boetzer M, Henkel CV, Jansen HJ, Butler D, Pirovano W. Scaffolding pre-assembled contigs using SSPACE. Bioinformatics. 2011;27:578–9.View ArticlePubMedGoogle Scholar
  22. Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, Edwards RA, et al. The RAST server: rapid annotations using subsystems technology. BMC Genomics. 2008;9:75.View ArticlePubMedPubMed CentralGoogle Scholar
  23. Zhou Y, Liang Y, Lynch KH, Dennis JJ, Wishart DSPHAST, Fast Phage A. Search tool. Nucleic Acids Res. 2011;39Google Scholar
  24. Jia B, Raphenya AR, Alcock B, Waglechner N, Guo P, Tsang KK, et al. CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database. Nucleic Acids Res. 2016;gkw1004.Google Scholar
  25. Wattam AR, Abraham D, Dalay O, Disz TL, Driscoll T, Gabbard JL, et al. PATRIC, the bacterial bioinformatics database and analysis resource. Nucleic Acids Res. 2014;42Google Scholar
  26. Carver TJ, Rutherford KM, Berriman M, Rajandream MA, Barrell BG, Parkhill JACT. The Artemis comparison tool. Bioinformatics. 2005;21:3422–3.View ArticlePubMedGoogle Scholar
  27. Amsterdam D. Antibiotics in Laboratory Medicine. 6th Editio. Philadelphia, PA; 2014.Google Scholar
  28. Moran NA. Microbial minimalism: genome reduction in bacterial pathogens. Cell. 2002:583–6.Google Scholar
  29. Gómez-Valero L, Rocha EPC, Latorre A, Silva FJ. Reconstructing the ancestor of mycobacterium leprae: the dynamics of gene loss and genome reduction. Genome Res. 2007;17:1178–85.View ArticlePubMedPubMed CentralGoogle Scholar
  30. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, et al. Deciphering the biology of mycobacterium tuberculosis from the\ncomplete genome sequence. Nature. 1998;393:537–44.View ArticlePubMedGoogle Scholar
  31. Driscoll JA, Brody SL, Kollef MH. The epidemiology, pathogenesis and treatment of Pseudomonas Aeruginosa infections. Drugs. 2007;67:351–68.View ArticlePubMedGoogle Scholar
  32. Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, et al. Complete genome sequence of Pseudomonas Aeruginosa PAO1, an opportunistic pathogen. Nature. 2000;406:959–64.View ArticlePubMedGoogle Scholar
  33. Sreejit G, Ahmed A, Parveen N, Jha V, Valluri VL, Ghosh S, et al. The ESAT-6 protein of mycobacterium tuberculosis interacts with Beta-2-microglobulin (β2M) affecting antigen presentation function of macrophage. PLoS Pathog. 2014;10Google Scholar
  34. Samten B, Wang X, Barnes PF. Mycobacterium tuberculosis ESX-1 system-secreted protein ESAT-6 but not CFP10 inhibits human T-cell immune responses. Tuberculosis. 2009;89 (Suppl 1):S74-S76.Google Scholar
  35. Backus KM, Dolan MA, Barry CS, Joe M, McPhie P, Boshoff HIM, et al. The three mycobacterium tuberculosis antigen 85 isoforms have unique substrates and activities determined by non-active site regions. J Biol Chem. 2014;289:25041–53.View ArticlePubMedPubMed CentralGoogle Scholar
  36. Hunter RL, Olsen MR, Jagannath C, Actor JK. Multiple roles of cord factor in the pathogenesis of primary, secondary, and cavitary tuberculosis, including a revised description of the pathology of secondary disease. Ann Clin Lab Sci. 2006;36:371–86.PubMedGoogle Scholar
  37. Zopf W. Ber ausscheidung von fettfarbstoffen (lipochromen) seitens gewisser spaltpilz. Berichte der Dtsch Bot Gesellschaf. 1891:22–8.Google Scholar
  38. Trevisan V. I. generi e le specie delle batteriacee. Zanaboni and Gabuzzi, Milano. 1889;Google Scholar
  39. Spargo BJ, Crowe LM, Ioneda T, Beaman BL, Crowe JH. Cord factor (alpha,alpha-trehalose 6,6′-dimycolate) inhibits fusion between phospholipid vesicles. Proc Natl Acad Sci U S A. 1991;88:737–40.View ArticlePubMedPubMed CentralGoogle Scholar
  40. Forrellad MA, Klepp LI, Gioffré A. Sabio y García J, Morbidoni HR, Santangelo M de la P, et al. Virulence factors of the Mycobacterium tuberculosis complex. Virulence. 2013;4:3–66.View ArticlePubMedPubMed CentralGoogle Scholar
  41. Pandey AK, Sassetti CM. Mycobacterial persistence requires the utilization of host cholesterol. Proc Natl Acad Sci U S A. 2008;105:4376–80.View ArticlePubMedPubMed CentralGoogle Scholar
  42. Clark LC, Seipke RF, Prieto P, Willemse J, van Wezel GP, Hutchings MI, et al. Mammalian cell entry genes in Streptomyces may provide clues to the evolution of bacterial virulence. Sci Rep. 2013;3:1109.View ArticlePubMedPubMed CentralGoogle Scholar
  43. Ahmad S, El-Shazly S, Mustafa AS, Al-Attiyah R. The six mammalian cell entry proteins (Mce3A-F) encoded by the mce3 operon are expressed during in vitro growth of mycobacterium tuberculosis. Scand J Immunol. 2005;62:16–24.View ArticlePubMedGoogle Scholar
  44. Forrellad M, McNeil M. Role of the Mce1 transporter in the lipid homeostasis of mycobacterium tuberculosis. Tuberc. 2014;94:170–7.View ArticleGoogle Scholar
  45. Waksman SA, Henrici AT. The nomenclature and classification of the Actinomycetes. J Bacteriol 1943;46:337–41.Google Scholar
  46. Migula W. Pseudomonas aeruginosa (schrter) mig. Gustav Fischer, Jena. 1900;2Google Scholar
  47. Kilpper-Balz R, Schleifer KH. Streptococcus Suis sp. nov., nom. Rev. Int J Syst Bacteriol. 1987;37:160–2.View ArticleGoogle Scholar
  48. Fulde M, Willenborg J, Huber C, Hitzmann A, Willms D, Seitz M, et al. The arginine-ornithine antiporter ArcD contributes to biological fitness of Streptococcus Suis. Front Cell Infect Microbiol. 2014;4:107.View ArticlePubMedPubMed CentralGoogle Scholar
  49. Boyce KJ, McLauchlan A, Schreider L, Andrianopoulos A, Intracellular Growth I. Dependent on tyrosine catabolism in the dimorphic fungal pathogen Penicillium marneffei. PLoS Pathog. 2015;11:1–30.View ArticleGoogle Scholar
  50. Greene GH, McGary KL, Rokas A, Slot JC. Ecology drives the distribution of specialized tyrosine metabolism modules in fungi. Genome Biol Evol. 2014;6:121–32.View ArticlePubMedPubMed CentralGoogle Scholar
  51. Field D, Garrity G, Gray T, Morrison N, Selengut J, Sterk P, et al. The minimum information about a genome sequences (MIGS) specification. Nat Biotechnol. 2008;26:541–7.View ArticlePubMedPubMed CentralGoogle Scholar
  52. Woese CR, Kandler O, Wheelis ML. Towards a natural system of organisms: proposal for the domains archaea, bacteria, and Eucarya. Proc Natl Acad Sci U S A. 1990;87:4576–9.View ArticlePubMedPubMed CentralGoogle Scholar
  53. Phylum GM, XXVI. Actinobacteria phyl. Nov. Bergey’s man. Syst. Bacteriol. 2012;3:33–4. https://doi.org/10.1601/nm.5711
  54. Stackebrandt E, Rainey F a., Ward-Rainey NL. Proposal for a new hierarchic classification system, Actinobacteria classis nov. Int J Syst Bacteriol 1997;47:479–491. https://doi.org/10.1601/nm.5712
  55. Zhi XY, Li WJ, Stackebrandt E. An update of the structure and 16S rRNA gene sequence-based definition of higher ranks of the class Actinobacteria, with the proposal of two new suborders and four new families and emended descriptions of the existing higher taxa. Int J Syst Evol Microbiol. 2009;59:589–608.View ArticlePubMedGoogle Scholar
  56. Skerman V, McGowan V, Sneath P. Approved lists of bacterial names. Int J Syst Bacteriol. 1980;2:225–420.View ArticleGoogle Scholar
  57. Chester F. Report of mycologist: bacteriological work. Delaware Agric Exp Stn Bull. 1897:59–80.Google Scholar
  58. Lehmann K, Neumann R. Atlas und Grundriss der Bakteriologie und Lehrbuch der speziellen bakteriologischen Diagnostik. First Ed. J.F. Lehmann, München. 1896.Google Scholar
  59. RE B, NE G. Bergey’s manual of determinative bacteriology. Balt: Williams Wilkins Co.; 1974.Google Scholar
  60. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. Nat Genet. 2000;25:25–9.View ArticlePubMedPubMed CentralGoogle Scholar
  61. Van Domselaar GH, Stothard P, Shrivastava S, Cruz JA, Guo AC, Dong X, et al. BASys: a web server for automated bacterial genome annotation. Nucleic Acids Res. 2005;33Google Scholar

Copyright

© The Author(s). 2018

Advertisement